ダニ媒介性脳炎の世界市場レポート 2025年

ダニ媒介性脳炎市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で142億1,000万米ドルに成長します。予測期間中に予測される成長は、ダニ媒介性脳炎の有病率の上昇、ヘルスケア施設に対する政府資金の増加、日本脳炎の発生率の増加、政府イニシアチブの拡大、中間層の増加などの要因によるものです。この時期の主な動向としては、ワクチン開発の進展、診断・治療法の技術革新、サーベイランスと制圧のための政府の取り組み、疾病伝播に影響を与える環境の変化、感染症制圧のための政府の取り組み強化などが挙げられます。

気候変動の影響の拡大は、今後ダニ媒介性脳炎市場の拡大を加速させると予想されます。気候変動とは、主に化石燃料の消費や森林伐採などの人間活動によって引き起こされる、地球の気温や気象パターンの長期的な変化を指します。地球の気温上昇は化石燃料の過剰燃焼の直接的な結果であり、二酸化炭素やメタンなどの温室効果ガスを大量に放出し、大気中に熱を閉じ込める。このような気温の上昇は、温暖な環境と穏やかな冬により、病気を媒介するマダニの生息域を拡大し、感染率の上昇と診断検査、ワクチン、抗ウイルス治療薬の需要増につながります。例えば、2024年11月、世界気象機関（WMO）は、エルニーニョ現象による温暖化の影響により、2024年1月から9月までの世界の平均気温が産業革命前平均を1.54℃上回ったと報告した（不確実性のマージンは+-0.13℃）。その結果、現在進行中の気候変動がダニ媒介性脳炎市場の成長を促進しています。

海外旅行の増加は、ダニ媒介性脳炎市場の成長をさらに押し上げると予想されます。海外旅行には、観光、ビジネス、教育、移住などの理由で国境を越えて人々が移動することが含まれます。可処分所得が増加するにつれて、レジャー、ビジネス、教育目的の国際旅行をする余裕のある人が増えています。このような海外旅行の増加は、ダニ媒介性脳炎の治療需要に寄与しています。というのも、ダニ媒介性脳炎が流行している地域を訪れる旅行者が増えることで、感染したダニにさらされる機会が増え、予防ワクチン接種や曝露後の治療の必要性が高まるからです。例えば、2025年1月、国連世界観光機関は、2024年には推定14億人が国際線を利用し、パンデミック以前のレベル（99％）にほぼ完全に回復し、2023年と比較して1億4,000万人の国際線利用者が増加したと報告しました。この旅行の急増がダニ媒介性脳炎市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ダニ媒介性脳炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のダニ媒介性脳炎市場：成長率分析
• 世界のダニ媒介性脳炎市場の実績：規模と成長, 2019-2024
• 世界のダニ媒介性脳炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界ダニ媒介性脳炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のダニ媒介性脳炎市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ダニ媒介性脳炎（TBE）ワクチン
• ダニ忌避剤
• 診断テスト
• 抗ウイルス薬
• 世界のダニ媒介性脳炎市場ウイルスの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 欧州のダニ媒介性脳炎ウイルス
• シベリアウイルス
• 極東のダニ媒介性脳炎ウイルス
• 世界のダニ媒介性脳炎市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非経口
• その他の投与経路
• 世界のダニ媒介性脳炎市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン
• オフライン
• 世界のダニ媒介性脳炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 旅行者
• アウトドア愛好家
• ヘルスケア提供者
• 調査機関
• 世界のダニ媒介性脳炎市場ダニ媒介性脳炎（TBE）ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化（殺菌）ワクチン
• 生弱毒化ワクチン
• 世界のダニ媒介性脳炎市場ダニ忌避剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DEETベースの忌避剤
• ピカリジン系忌避剤
• 天然または植物由来の忌避剤
• ペルメトリン処理された衣類とギア
• 世界のダニ媒介性脳炎市場診断検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ELISA（酵素免疫測定法）
• PCR（ポリメラーゼ連鎖反応）
• 迅速診断検査（RDT）
• 中和試験
• 世界のダニ媒介性脳炎市場抗ウイルス薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヌクレオシド類似体
• インターフェロン
• 免疫グロブリン療法
• 支持療法（治療）

第7章 地域別・国別分析

• 世界のダニ媒介性脳炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のダニ媒介性脳炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ダニ媒介性脳炎市場：競合情勢
• ダニ媒介性脳炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Health Mil Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline（GSK）Plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Mayo Clinic
• Superdrug Health Clinic
• Bavarian Nordic
• Passport Health
• Valneva SE
• Microgen
• Travel Doctor-TMVC
• DIESSE Diagnostica Senese S.p.A.
• The Native Antigen Company
• Fleet Street Clinic
• Progen
• Smarta Healthcare
• QED Bioscience Inc.
• Serion Immunologics
• Chumakov Federal Scientific Center

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ダニ媒介性脳炎市場2029：新たな機会を提供する国
• ダニ媒介性脳炎市場2029：新たな機会を提供するセグメント
• ダニ媒介性脳炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tick-borne encephalitis (TBE) is a viral infection transmitted to humans through the bite of an infected tick, primarily the Ixodes species. The virus targets the central nervous system, leading to brain inflammation (encephalitis). Symptoms can range from mild flu-like signs to severe neurological issues, including fever, headache, confusion, and, in some cases, paralysis or seizures.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main products used for tick-borne encephalitis (TBE) include TBE vaccines, tick repellents, diagnostic tests, and antiviral drugs. TBE vaccines are biological preparations designed to stimulate the immune system to recognize and fight the TBE virus. The virus is caused by several types, including the European tick-borne encephalitis virus, Siberian tick-borne encephalitis virus, and Far Eastern tick-borne encephalitis virus. These vaccines can be administered through parenteral and other routes. They are distributed via both online and offline channels and are used by travelers, outdoor enthusiasts, healthcare providers, and research institutions.

The tick borne encephalitis market research report is one of a series of new reports from The Business Research Company that provides tick borne encephalitis market statistics, including tick borne encephalitis industry global market size, regional shares, competitors with a tick borne encephalitis market share, detailed tick borne encephalitis market segments, market trends and opportunities, and any further data you may need to thrive in the tick borne encephalitis industry. This tick borne encephalitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tick borne encephalitis market size has grown strongly in recent years. It will grow from $9.77 billion in 2024 to $10.56 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historic period can be attributed to several factors, including a growing geriatric population, an increasing incidence of tick bites, a rise in the disease's prevalence, and a growing demand for effective and safe vaccines.

The tick borne encephalitis market size is expected to see strong growth in the next few years. It will grow to $14.21 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth projected for the forecast period can be attributed to factors such as the rising prevalence of tick-borne encephalitis, increasing government funding for healthcare facilities, a growing incidence of Japanese encephalitis, expanding government initiatives, and the rising middle class. Key trends during this period include advancements in vaccine development, technological innovations in diagnostics and therapeutics, government initiatives for surveillance and control, environmental changes affecting disease transmission, and enhanced government efforts for infectious disease control.

The growing effects of climate change are expected to accelerate the expansion of the tick-borne encephalitis market in the future. Climate change refers to the long-term changes in global temperature and weather patterns, primarily caused by human activities such as fossil fuel consumption and deforestation. The rise in global temperatures is a direct result of excessive fossil fuel burning, which releases significant amounts of greenhouse gases such as carbon dioxide and methane, trapping heat in the atmosphere. This increase in temperature helps expand the habitats of ticks that carry diseases, due to warmer conditions and milder winters, leading to higher infection rates and an increased demand for diagnostic tests, vaccines, and antiviral treatments. For instance, in November 2024, the World Meteorological Organization (WMO) reported that from January to September 2024, the global mean surface air temperature was 1.54°C above the pre-industrial average (+-0.13°C margin of uncertainty), driven by the warming effects of the El Nino event. Consequently, the ongoing climate change is driving the growth of the tick-borne encephalitis market.

The increase in international travel is anticipated to further boost the growth of the tick-borne encephalitis market. International travel involves the movement of people across borders for reasons such as tourism, business, education, or migration. As disposable income rises, more people are able to afford leisure, business, and educational trips internationally. This rise in international travel contributes to the demand for tick-borne encephalitis treatment, as more travelers visit regions where the disease is endemic, increasing their exposure to infected ticks and the need for preventive vaccinations and medical care following exposure. For example, in January 2025, the United Nations World Tourism Organization reported that an estimated 1.4 billion people traveled internationally in 2024, marking a near-full recovery to pre-pandemic levels (99%), with 140 million more international arrivals compared to 2023. This surge in travel drives the growth of the tick-borne encephalitis market.

The rising government investment in healthcare is expected to accelerate the growth of the tick-borne encephalitis market moving forward. Government funding refers to financial support provided to organizations, projects, or individuals to promote public services, economic development, research, or other policy goals. This increase in funding is primarily due to heightened investments in public health and infrastructure, as governments allocate more resources to bolster healthcare systems, support economic recovery, and boost research and development. Government funding has a positive impact on the tick-borne encephalitis market by supporting vaccination campaigns, expanding immunization efforts in endemic regions, reducing infection rates, and increasing public access to preventive healthcare. For example, in May 2024, a report from the Office for National Statistics indicated that in 2023, the UK government's expenditure accounted for the majority of healthcare financing, totaling $309 billion (£239 billion), or 81.9% of overall healthcare spending. Thus, growing government healthcare funding is driving the growth of the tick-borne encephalitis market.

Major players in the tick borne encephalitis market are Pfizer Inc., Health Mil, Sanofi Pasteur, Novartis AG, GlaxoSmithKline (GSK) Plc, Mayo Clinic, Superdrug Health Clinic, Bavarian Nordic, Passport Health, Valneva SE, Microgen, Travel Doctor-TMVC, DIESSE Diagnostica Senese S.p.A., The Native Antigen Company, Fleet Street Clinic, Progen, Smarta Healthcare, QED Bioscience Inc., Serion Immunologics, Chumakov Federal Scientific Center.

Europe was the largest region in the tick borne encephalitis market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in tick-borne encephalitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tick-borne encephalitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tick-borne encephalitis market consists of sales of immune globulins, protective clothing and tick barriers, and surveillance and monitoring systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tick Borne Encephalitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tick borne encephalitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tick borne encephalitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tick borne encephalitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Tick-Borne Encephalitis (TBE) Vaccines; Tick Repellents; Diagnostic Tests; Antiviral Drugs
• 2) By Virus Type: European Tick Borne Encephalitis Virus; Siberian Tick Borne Encephalitis Virus; Far Eastern Tick Borne Encephalitis Virus
• 3) By Route of Administration: Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Online; Offline
• 5) By End-User: Travelers; Outdoor Enthusiasts; Healthcare Providers; Research Institutions
• Subsegments:
• 1) By Tick-Borne Encephalitis (TBE) Vaccines: Inactivated (Killed) Vaccines; Live Attenuated Vaccines
• 2) By Tick Repellents: DEET-Based Repellents; Picaridin-Based Repellents; Natural Or Plant-Based Repellents; Permethrin-Treated Clothing And Gear
• 3) By Diagnostic Tests: ELISA (Enzyme-Linked Immunosorbent Assay); PCR (Polymerase Chain Reaction); Rapid Diagnostic Tests (RDTs); Neutralization Tests
• 4) By Antiviral Drugs: Nucleoside Analogs; Interferons; Immunoglobulin Therapy; Supportive Therapy (Symptomatic Treatment)
• Companies Mentioned: Pfizer Inc.; Health Mil; Sanofi Pasteur; Novartis AG; GlaxoSmithKline (GSK) Plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tick Borne Encephalitis Market Characteristics

3. Tick Borne Encephalitis Market Trends And Strategies

4. Tick Borne Encephalitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Tick Borne Encephalitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tick Borne Encephalitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tick Borne Encephalitis Market Growth Rate Analysis
• 5.4. Global Tick Borne Encephalitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tick Borne Encephalitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tick Borne Encephalitis Total Addressable Market (TAM)

6. Tick Borne Encephalitis Market Segmentation

• 6.1. Global Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tick-Borne Encephalitis (TBE) Vaccines
• Tick Repellents
• Diagnostic Tests
• Antiviral Drugs
• 6.2. Global Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• European Tick Borne Encephalitis Virus
• Siberian Tick Borne Encephalitis Virus
• Far Eastern Tick Borne Encephalitis Virus
• 6.3. Global Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral
• Other Routes Of Administration
• 6.4. Global Tick Borne Encephalitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.5. Global Tick Borne Encephalitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Travelers
• Outdoor Enthusiasts
• Healthcare Providers
• Research Institutions
• 6.6. Global Tick Borne Encephalitis Market, Sub-Segmentation Of Tick-Borne Encephalitis (TBE) Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated (Killed) Vaccines
• Live Attenuated Vaccines
• 6.7. Global Tick Borne Encephalitis Market, Sub-Segmentation Of Tick Repellents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DEET-Based Repellents
• Picaridin-Based Repellents
• Natural Or Plant-Based Repellents
• Permethrin-Treated Clothing And Gear
• 6.8. Global Tick Borne Encephalitis Market, Sub-Segmentation Of Diagnostic Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA (Enzyme-Linked Immunosorbent Assay)
• PCR (Polymerase Chain Reaction)
• Rapid Diagnostic Tests (RDTs)
• Neutralization Tests
• 6.9. Global Tick Borne Encephalitis Market, Sub-Segmentation Of Antiviral Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleoside Analogs
• Interferons
• Immunoglobulin Therapy
• Supportive Therapy (Symptomatic Treatment)

7. Tick Borne Encephalitis Market Regional And Country Analysis

• 7.1. Global Tick Borne Encephalitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tick Borne Encephalitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tick Borne Encephalitis Market

• 8.1. Asia-Pacific Tick Borne Encephalitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tick Borne Encephalitis Market

• 9.1. China Tick Borne Encephalitis Market Overview
• 9.2. China Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tick Borne Encephalitis Market

• 10.1. India Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tick Borne Encephalitis Market

• 11.1. Japan Tick Borne Encephalitis Market Overview
• 11.2. Japan Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tick Borne Encephalitis Market

• 12.1. Australia Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tick Borne Encephalitis Market

• 13.1. Indonesia Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tick Borne Encephalitis Market

• 14.1. South Korea Tick Borne Encephalitis Market Overview
• 14.2. South Korea Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tick Borne Encephalitis Market

• 15.1. Western Europe Tick Borne Encephalitis Market Overview
• 15.2. Western Europe Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tick Borne Encephalitis Market

• 16.1. UK Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tick Borne Encephalitis Market

• 17.1. Germany Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tick Borne Encephalitis Market

• 18.1. France Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tick Borne Encephalitis Market

• 19.1. Italy Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tick Borne Encephalitis Market

• 20.1. Spain Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tick Borne Encephalitis Market

• 21.1. Eastern Europe Tick Borne Encephalitis Market Overview
• 21.2. Eastern Europe Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tick Borne Encephalitis Market

• 22.1. Russia Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tick Borne Encephalitis Market

• 23.1. North America Tick Borne Encephalitis Market Overview
• 23.2. North America Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tick Borne Encephalitis Market

• 24.1. USA Tick Borne Encephalitis Market Overview
• 24.2. USA Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tick Borne Encephalitis Market

• 25.1. Canada Tick Borne Encephalitis Market Overview
• 25.2. Canada Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tick Borne Encephalitis Market

• 26.1. South America Tick Borne Encephalitis Market Overview
• 26.2. South America Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tick Borne Encephalitis Market

• 27.1. Brazil Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tick Borne Encephalitis Market

• 28.1. Middle East Tick Borne Encephalitis Market Overview
• 28.2. Middle East Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tick Borne Encephalitis Market

• 29.1. Africa Tick Borne Encephalitis Market Overview
• 29.2. Africa Tick Borne Encephalitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tick Borne Encephalitis Market, Segmentation By Virus Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tick Borne Encephalitis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tick Borne Encephalitis Market Competitive Landscape And Company Profiles

• 30.1. Tick Borne Encephalitis Market Competitive Landscape
• 30.2. Tick Borne Encephalitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Health Mil Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline (GSK) Plc Overview, Products and Services, Strategy and Financial Analysis

31. Tick Borne Encephalitis Market Other Major And Innovative Companies

• 31.1. Mayo Clinic
• 31.2. Superdrug Health Clinic
• 31.3. Bavarian Nordic
• 31.4. Passport Health
• 31.5. Valneva SE
• 31.6. Microgen
• 31.7. Travel Doctor-TMVC
• 31.8. DIESSE Diagnostica Senese S.p.A.
• 31.9. The Native Antigen Company
• 31.10. Fleet Street Clinic
• 31.11. Progen
• 31.12. Smarta Healthcare
• 31.13. QED Bioscience Inc.
• 31.14. Serion Immunologics
• 31.15. Chumakov Federal Scientific Center

32. Global Tick Borne Encephalitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tick Borne Encephalitis Market

34. Recent Developments In The Tick Borne Encephalitis Market

35. Tick Borne Encephalitis Market High Potential Countries, Segments and Strategies

• 35.1 Tick Borne Encephalitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tick Borne Encephalitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tick Borne Encephalitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34994_Tick_Borne_Encephalitis_GMR_2025